Caffeine, CYPA12 and Resistance Training

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions
CYP1A2 PolymorphismCaffeine and Resistance Training
Interventions
DIETARY_SUPPLEMENT

Caffeine and Resistance training

Acute caffeine intake (3 mg/kg) prior each resistance training session of a 8 weeks training program.

DIETARY_SUPPLEMENT

Placebo and Resistance training

Acute placebo intake (3 mg/kg of maltodextrin) prior each resistance training session of a 8 weeks training program.

Trial Locations (1)

28805

RECRUITING

Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá, Alcalá de Henares

All Listed Sponsors
collaborator

University of Alcala

OTHER

collaborator

iSanidad+Herbalife

UNKNOWN

lead

Alberto Pérez-López

OTHER

NCT06610123 - Caffeine, CYPA12 and Resistance Training | Biotech Hunter | Biotech Hunter